IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 2 filers reported holding IMPAX LABORATORIES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,901,000 | +16.9% | 97,500 | -0.2% | 0.01% | +25.0% |
| Q4 2017 | $1,626,000 | -23.6% | 97,672 | -3.2% | 0.00% | -20.0% |
| Q3 2017 | $2,128,000 | +24.1% | 100,872 | -5.6% | 0.01% | 0.0% |
| Q2 2017 | $1,715,000 | +31.5% | 106,856 | +3.2% | 0.01% | +25.0% |
| Q1 2017 | $1,304,000 | +2.2% | 103,506 | +7.6% | 0.00% | 0.0% |
| Q4 2016 | $1,276,000 | -72.9% | 96,208 | -51.5% | 0.00% | -42.9% |
| Q3 2016 | $4,704,000 | +79.9% | 198,546 | +118.7% | 0.01% | -12.5% |
| Q2 2016 | $2,615,000 | +929.5% | 90,789 | +1044.0% | 0.01% | +700.0% |
| Q1 2016 | $254,000 | -3.1% | 7,936 | +29.5% | 0.00% | 0.0% |
| Q4 2015 | $262,000 | +21.3% | 6,126 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $216,000 | -89.0% | 6,126 | -85.7% | 0.00% | -85.7% |
| Q2 2015 | $1,969,000 | -26.1% | 42,926 | -24.7% | 0.01% | -22.2% |
| Q1 2015 | $2,665,000 | +27.5% | 57,026 | -13.5% | 0.01% | +28.6% |
| Q4 2014 | $2,091,000 | +35.2% | 65,926 | +1.1% | 0.01% | +40.0% |
| Q3 2014 | $1,547,000 | +1416.7% | 65,226 | +1803.9% | 0.01% | – |
| Q2 2014 | $102,000 | +13.3% | 3,426 | 0.0% | 0.00% | – |
| Q1 2014 | $90,000 | +3.4% | 3,426 | 0.0% | 0.00% | – |
| Q4 2013 | $87,000 | – | 3,426 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |